Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Colucid Pharma Cmn (CLCD)

Colucid Pharma Cmn (CLCD)
46.53 +0.03 (+0.06%) 02/28/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Tue, Feb 28th, 2017
Day Low
46.45
Day High
46.55
Open 46.50
Previous Close 46.50 46.50
Volume 127,000 127,000
Avg Vol 245,780 245,780
Stochastic %K 53.33% 53.33%
Weighted Alpha +162.70 +162.70
5-Day Change +0.03 (+0.06%) +0.03 (+0.06%)
52-Week Range 5.26 - 46.65 5.26 - 46.65
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 897,098
  • Shares Outstanding, K 19,280
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,740 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.55
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.70
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/01/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/16
See More
  • Average Estimate -0.88
  • Number of Estimates 2
  • High Estimate -0.85
  • Low Estimate -0.91
  • Prior Year -0.74
  • Growth Rate Est. (year over year) -18.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.20 +0.71%
on 01/30/17
Period Open: 46.25
46.65 -0.26%
on 02/08/17
+0.28 (+0.61%)
since 01/27/17
3-Month
31.25 +48.90%
on 01/06/17
Period Open: 33.90
46.65 -0.26%
on 02/08/17
+12.63 (+37.26%)
since 11/28/16
52-Week
5.26 +784.60%
on 05/09/16
Period Open: 5.66
46.65 -0.26%
on 02/08/17
+40.87 (+722.08%)
since 02/26/16

Business Summary

CoLucid Pharmaceuticals, Inc. is a biopharmaceutical company which develops molecule for the treatment of migraine headaches. The company's product candidate consists of oral Lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain, which are in different...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 46.61
1st Resistance Point 46.57
Last Price 46.53
1st Support Level 46.47
2nd Support Level 46.41
3rd Support Level N/A

See More

52-Week High 46.65
Last Price 46.53
Fibonacci 61.8% 30.84
Fibonacci 50% 25.96
Fibonacci 38.2% 21.07
52-Week Low 5.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Master Swing Trading: Strategies for Momentum and Trends